NM_000155.4:c.667C>T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_000155.4(GALT):c.667C>T(p.Arg223Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,613,998 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000155.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALT | ENST00000378842.8 | c.667C>T | p.Arg223Cys | missense_variant | Exon 7 of 11 | 1 | NM_000155.4 | ENSP00000368119.4 | ||
ENSG00000258728 | ENST00000556278.1 | c.412C>T | p.Arg138Cys | missense_variant | Exon 4 of 8 | 5 | ENSP00000451792.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251460Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135910
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461872Hom.: 0 Cov.: 33 AF XY: 0.0000220 AC XY: 16AN XY: 727236
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74314
ClinVar
Submissions by phenotype
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase Pathogenic:2
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 223 of the GALT protein (p.Arg223Cys). This variant is present in population databases (rs111033750, gnomAD 0.008%). This missense change has been observed in individual(s) with galactose-1-phosphate uridylyltransferase deficiency (Invitae). ClinVar contains an entry for this variant (Variation ID: 529225). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GALT protein function with a positive predictive value of 95%. This variant disrupts the p.Arg223 amino acid residue in GALT. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17876724, 22461411). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Premature ovarian failure Pathogenic:1
- -
GALT-related disorder Uncertain:1
The GALT c.667C>T variant is predicted to result in the amino acid substitution p.Arg223Cys. This variant was reported in the heterozygous state without a second GALT variant in an individual with primary ovarian insufficiency (described as c.C304T, p.R114C in Bestetti et al. 2021. PubMed ID: 34480478). We have observed this variant along with the Duarte variant in an individual with an abnormal newborn screen for galactosemia (PreventionGenetics internal data). Additionally, a different substitution of the same amino acid (p.Arg223Ser) was reported along with a known pathogenic GALT variant in a study of individuals with abnormal newborn screening results for galactosemia (Calderon et al. 2007. PubMed ID: 17876724). This variant is reported in 0.012% of alleles in individuals of European (Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-34648433-C-T). Although we suspect this variant may be pathogenic, at this time its clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. -
Galactosemia Uncertain:1
- -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at